Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI

Go back to Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
(NASDAQ: CMND) Delayed: 0.79 --0 (-0%)
Previous Close $0.79    52 Week High
Open $0.79    52 Week Low
Day High $0.79    P/E N/A 
Day Low $0.79    EPS
Volume 13,409